Please provide your email address to receive an email when new articles are posted on . At 52 weeks, MASH resolution without worsening of fibrosis was reported among 36% on denifanstat vs. 13% on ...
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
Digital pathology assisted by artificial intelligence (AI) has the potential to transform the diagnosis and treatment of fibrotic liver disease in the next few years and to reshape clinical trials, ...
HKUMed reveals that Resmetirom, a drug for treating metabolic dysfunction-associated fatty liver disease (MAFLD), has the ...
A risky but often lifesaving surgery that removes damaged parts of the small intestine can leave patients facing a new threat ...
New research shows that Vitamin E therapy significantly enhances liver function and reduces inflammation in MASH patients, providing a safer and effective treatment option in the fight against ...
Researchers developed a compound that protects the liver after small bowel resection in mice. The drug improved nutrient ...
Fatty liver is rising even among non-drinkers. A gastroenterologist explains the causes, lifestyle risks, early warning signs ...
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr Amanda Hemmerich.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results